These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 24094652

  • 1. Assessment of deoxyribonucleic acid fragmentation index, testicular volume, semen parameters, and hormone profile in gonadotropin-treated men with hypogonadotropic hypogonadism.
    Hosseinifar H, Sabbaghian M, Chehrazi M, Modarresi T, Alipour FJ, Sadighi Gilani MA.
    Urology; 2013 Dec; 82(6):1291-5. PubMed ID: 24094652
    [Abstract] [Full Text] [Related]

  • 2. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L, Banks SM, Barnes KM, Sherins RJ.
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [Abstract] [Full Text] [Related]

  • 3. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB, Leonard JM.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Full-term delivery following intracytoplasmic sperm injection in a case of male hypogonadotropic hypogonadism after 8-year treatment with HCG and HMG].
    Amano T, Imao T, Takemae K, Mizusawa H, Miura H.
    Hinyokika Kiyo; 2008 Apr; 54(4):313-6. PubMed ID: 18516929
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis.
    Zacharin M, Sabin MA, Nair VV, Dabadghao P.
    Fertil Steril; 2012 Oct; 98(4):836-42. PubMed ID: 22763096
    [Abstract] [Full Text] [Related]

  • 8. Seminal anti-Müllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism.
    Sinisi AA, Esposito D, Maione L, Quinto MC, Visconti D, De Bellis A, Bellastella A, Conzo G, Bellastella G.
    Hum Reprod; 2008 May; 23(5):1029-34. PubMed ID: 18343809
    [Abstract] [Full Text] [Related]

  • 9. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
    Lin J, Mao J, Wang X, Ma W, Hao M, Wu X.
    Medicine (Baltimore); 2019 Aug; 98(31):e16616. PubMed ID: 31374027
    [Abstract] [Full Text] [Related]

  • 10. An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism.
    Nieschlag E, Bouloux PG, Stegmann BJ, Shankar RR, Guan Y, Tzontcheva A, McCrary Sisk C, Behre HM.
    Reprod Biol Endocrinol; 2017 Mar 07; 15(1):17. PubMed ID: 28270212
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF, Liu ZX, Nie M, Wang X, Xu HL, Huang BK, Zheng JJ, Min L, Kaiser UB, Wu XY.
    Asian J Androl; 2017 Mar 07; 19(6):680-685. PubMed ID: 28051040
    [Abstract] [Full Text] [Related]

  • 14. Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults.
    Rohayem J, Sinthofen N, Nieschlag E, Kliesch S, Zitzmann M.
    Andrology; 2016 Jan 07; 4(1):87-94. PubMed ID: 26779870
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study.
    Miyagawa Y, Tsujimura A, Matsumiya K, Takao T, Tohda A, Koga M, Takeyama M, Fujioka H, Takada S, Koide T, Okuyama A.
    J Urol; 2005 Jun 07; 173(6):2072-5. PubMed ID: 15879837
    [Abstract] [Full Text] [Related]

  • 17. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M, Nie M, Yu BQ, Gao YJ, Wang X, Ma WL, Huang QB, Zhang R, Mao JF, Wu XY.
    Asian J Androl; 2020 Jun 07; 22(4):390-395. PubMed ID: 31464203
    [Abstract] [Full Text] [Related]

  • 18. Induction of fertility in a man with hypogonadotropic hypogonadism with very low seminal volume.
    Tulandi T, McInnes RA.
    Fertil Steril; 1986 Oct 07; 46(4):730-3. PubMed ID: 3093284
    [Abstract] [Full Text] [Related]

  • 19. Induction of spermatogenesis in isolated hypogonadotrophic hypogonadism with gonadotrophins and early intervention with intracytoplasmic sperm injection.
    Yong EL, Lee KO, Ng SC, Ratnam SS.
    Hum Reprod; 1997 Jun 07; 12(6):1230-2. PubMed ID: 9222007
    [Abstract] [Full Text] [Related]

  • 20. Sperm deoxyribonucleic acid fragmentation as a prognostic indicator of assisted reproductive technology outcome.
    Benchaib M, Lornage J, Mazoyer C, Lejeune H, Salle B, François Guerin J.
    Fertil Steril; 2007 Jan 07; 87(1):93-100. PubMed ID: 17074327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.